AC
BSX icon

Apogem Capital’s Boston Scientific BSX Stock Holding History

Apogem Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,669
Closed -$452K – 14
2022
Q3 		$452K Buy
11,669
+3,716
+47% +$149K 0.45% 72
2022
Q2 		$296K Buy
7,953
+484
+6% +$19.7K 0.27% 113
2022
Q1 		$331K Buy
+7,469
New +$324K 0.23% 124

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Apogem Capital's BSX Position: Q4 2022 in Review

Apogem Capital sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 11,669 shares — an estimated $452K sold.

Apogem Capital first reported a position in BSX in Q1 2022 and held it in 3 quarters. The position peaked at $452K in Q3 2022. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Apogem Capital reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • Apogem Capital sold 11,669 Boston Scientific shares in Q4 2022, an estimated $452K.
  • Apogem Capital first reported a position in Boston Scientific in Q1 2022 and held it in 3 quarters.
  • Apogem Capital's Boston Scientific position peaked at $452K in Q3 2022.
  • 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Apogem Capital's 13F filing for Q4 2022, filed 13 Feb 2023.